Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Calcium binding protein 39-like (CAB39L) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the CAB39L transcript that governs the expression of the CAB39L protein, also known as MO25-beta (UniProt: Q9H9S4). CAB39L serves as a vital scaffold component of the LKB1-STRAD-CAB39L heterotrimeric complex, which is necessary for the full activation of Liver Kinase B1 (LKB1), a master upstream kinase of the AMP-activated protein kinase (AMPK) family (NCBI Gene: 27279). The 3'-UTR of CAB39L contains multiple seed sequences for microRNAs, such as miR-107 and miR-497, which negatively regulate its expression through translational inhibition or mRNA decay (PubMed: 25670101). In various malignancies, including gastric cancer and nasopharyngeal carcinoma, the downregulation of CAB39L via its 3'-UTR is associated with increased cell proliferation, migration, and resistance to apoptosis (PubMed: 29130515). Consequently, the CAB39L mRNA 3'-UTR is an emerging focal point for RNA-based therapeutic interventions designed to modulate the LKB1/AMPK signaling axis in cancer and metabolic diseases. Experimental strategies targeting this region include miRNA mimics to suppress oncogenic signaling or antisense oligonucleotides to stabilize the transcript in tumor-suppressive contexts.
MicroRNA-mediated gene silencing or antisense-mediated modulation of mRNA stability and translation to regulate CAB39L protein levels.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium binding protein 39-like mRNA 3'-untranslated region (CAB39L mRNA 3'-UTR).